enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Does Medicare Cover the Prostate-Specific Antigen (PSA) Test?

   www.aol.com/does-medicare-cover-prostate...

   Medicare typically covers annual preventive care, including the PSA test, if you meet the eligibility criteria. Learn more.

3. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   The 4Kscore combines total, free and intact PSA together with human kallikrein 2. [46] It is used to try to determine the risk of a Gleason score greater than 6. [46] The Prostate Health Index (PHI) is a PSA-based blood test for early prostate cancer screening. It may be used to determine when a biopsy is needed.

4. Prostate-specific antigen - Wikipedia

   en.wikipedia.org/wiki/Prostate-specific_antigen

   Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.

5. Cancer screening - Wikipedia

   en.wikipedia.org/wiki/Cancer_screening

   While many screening tests (such as the fecal occult blood test or PSA test) are non-invasive, it is important to note that mammography (breast cancer screening) involves ionizing radiation exposure. [10] The breast is highly radiation sensitive, and it receives an approximate dose of 2.6 milligrays per mammography screening. [11]

6. What Your PSA Test Says About Your Prostate - AOL

   www.aol.com/lifestyle/psa-test-says-prostate...

   For premium support please call: 800-290-4726 more ways to reach us

7. Richard J. Ablin - Wikipedia

   en.wikipedia.org/wiki/Richard_J._Ablin

   Richard J. Ablin (May 15, 1940 – October 6, 2023) [1] was an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening.